Your Health. Your Family. Your Choice.
Administered by: Private Purchased by: Other
Life Threatening? Yes
Write-up: This case was reported by a physician and described the occurrence of intussusception in a 2-month-old female subject who was vaccinated with ROTARIX (GlaxoSmithKline). Concurrent vaccination included DTaP-IPV/HepB; GlaxoSmithKline; unknown; unknown given on 14 January 2014; Hib (non-gsk); non-GSK manufacturer; unknown; unknown given on 14 January 2014; pneumococcal vaccines (non-gsk); non-GSK manufacturer; unknown; unknown given on 14 January 2014. On 14 January 2014 at 09:36 the subject received 1st dose of ROTARIX (1 ml, oral). On 19 January 2014, 5 days after vaccination with ROTARIX, the subject experienced intussusception. The subject was hospitalised and the physician considered the event was life threatening and clinically significant (or requiring intervention). At the time of reporting the event was resolved. The vaccination course with ROTARIX was discontinued. The physician considered the event was probably related to vaccination with ROTARIX.
Copyright © 2018 National Vaccine Information Center. All rights reserved.
21525 Ridgetop Circle, Suite 100, Sterling, VA 20166